DK1067934T3 - Flydende oral opløsning omfattende det anti-depressive middel mirtazapin - Google Patents

Flydende oral opløsning omfattende det anti-depressive middel mirtazapin

Info

Publication number: DK1067934T3
Authority: DK; Denmark
Prior art keywords: mirtazapine; oral solution; liquid oral; antidepressant mirtazapine; antidepressant
Prior art date: 1998-04-02

Application number

DK99917956T

Other languages

Danish (da)

English (en)

Inventor

Arnold Titus Philip Skrabanja

Roger Edward Tully

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-02

Filing date

1999-03-29

Publication date

2004-03-29

1999-03-29 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

2004-03-29 Application granted granted Critical

2004-03-29 Publication of DK1067934T3 publication Critical patent/DK1067934T3/da

Links

229960001785 mirtazapine Drugs 0.000 title abstract 3
RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 title abstract 3
230000001430 anti-depressive effect Effects 0.000 title abstract 2
239000000935 antidepressant agent Substances 0.000 title abstract 2
229940005513 antidepressants Drugs 0.000 title 1
239000007788 liquid Substances 0.000 title 1
229940100688 oral solution Drugs 0.000 title 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
230000003444 anaesthetic effect Effects 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
239000007900 aqueous suspension Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000003589 local anesthetic agent Substances 0.000 abstract 1
229930182817 methionine Natural products 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Cosmetics (AREA)

DK99917956T 1998-04-02 1999-03-29 Flydende oral opløsning omfattende det anti-depressive middel mirtazapin DK1067934T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98201037		1998-04-02
PCT/EP1999/002277 WO1999051237A1 (en)	1998-04-02	1999-03-29	Oral liquid antidepressant solution

Publications (1)

Publication Number	Publication Date
DK1067934T3 true DK1067934T3 (da)	2004-03-29

Family

ID=8233550

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99917956T DK1067934T3 (da)	1998-04-02	1999-03-29	Flydende oral opløsning omfattende det anti-depressive middel mirtazapin

Country Status (11)

Country	Link
US (2)	US6040301A (de)
EP (1)	EP1067934B1 (de)
AT (1)	ATE254918T1 (de)
AU (1)	AU747975B2 (de)
BR (1)	BR9909357A (de)
CA (1)	CA2326356C (de)
DE (1)	DE69913116T2 (de)
DK (1)	DK1067934T3 (de)
ES (1)	ES2212550T3 (de)
PT (1)	PT1067934E (de)
WO (1)	WO1999051237A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6495534B2 (en) *	2000-05-15	2002-12-17	Pharmacia & Upjohn Spa	Stabilized aqueous suspensions for parenteral use
WO2002064735A2 (en) *	2001-02-12	2002-08-22	Akzo Nobel N.V.	Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4
US6399310B1 (en)	2001-02-12	2002-06-04	Akzo Nobel N.V.	Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
US20030105082A1 (en) *	2001-12-03	2003-06-05	Murphy Greer Marechal	Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
US20040156894A1 (en) *	2003-02-07	2004-08-12	Grother Leon Paul	Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
US7838029B1 (en)	2003-07-31	2010-11-23	Watson Laboratories, Inc.	Mirtazapine solid dosage forms
TW200538100A (en) *	2004-04-21	2005-12-01	Akzo Nobel Nv	Mirtazapine salts
US20060039866A1 (en) *	2004-08-20	2006-02-23	Cypress Bioscience, Inc.	Method for treating sleep-related breathing disorders
CA2581076A1 (en) *	2004-09-14	2006-03-23	Molecular Therapeutics, Inc.	D-methionine formulation with improved biopharmaceutical properties
CA2586688A1 (en) *	2004-11-08	2006-05-18	New River Pharmaceuticals Inc.	Synergistic effects of combined administration of mirtazapine and a stimulant compound
TW200631584A (en) *	2004-11-15	2006-09-16	Akzo Nobel Nv	A medicament related to mirtazapine for the treatment of hot flush
EP1827450A4 (de) *	2004-11-17	2009-04-22	Cypress Bioscience Inc	Verfahren zur verringerung der nebenwirkungen einer behandlung mit mirtazapin
EP2167096A4 (de) *	2007-06-13	2010-07-14	Cypress Bioscience Inc	Verbesserung der verträglichkeit von mirtazapin und eines zweiten wirkstoffes durch ihre kombinierte verwendung
CN102939436B (zh)	2010-05-05	2016-03-23	能量转子股份有限公司	流体能量转换装置
US8714951B2 (en) *	2011-08-05	2014-05-06	Ener-G-Rotors, Inc.	Fluid energy transfer device
PT3261645T (pt)	2015-02-27	2021-06-17	Dechra Ltd	Estimulação do apetite, gestão da perda de peso, e tratamento da anorexia em cães e gatos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL189199C (nl) *	1975-04-05	1993-02-01	Akzo Nv	Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US5208261A (en) *	1989-12-06	1993-05-04	Akzo N.V.	Stabilized solutions of psychotropic agents
DK0431663T3 (da) *	1989-12-06	1994-03-07	Akzo Nobel Nv	Stabiliserende opløsninger af psykotrope midler
IE63986B1 (en) *	1989-12-30	1995-06-28	Akzo Nv	Pharmaceutical preparation for oral administration in fluid form
US5238699A (en) *	1991-11-27	1993-08-24	Kraft General Foods, Inc.	Ready-to-eat, low/no-fat puddings and process

1999
- 1999-03-29 DK DK99917956T patent/DK1067934T3/da active
- 1999-03-29 AU AU36048/99A patent/AU747975B2/en not_active Ceased
- 1999-03-29 DE DE69913116T patent/DE69913116T2/de not_active Expired - Lifetime
- 1999-03-29 ES ES99917956T patent/ES2212550T3/es not_active Expired - Lifetime
- 1999-03-29 CA CA002326356A patent/CA2326356C/en not_active Expired - Fee Related
- 1999-03-29 AT AT99917956T patent/ATE254918T1/de active
- 1999-03-29 EP EP99917956A patent/EP1067934B1/de not_active Expired - Lifetime
- 1999-03-29 BR BR9909357-0A patent/BR9909357A/pt not_active Application Discontinuation
- 1999-03-29 PT PT99917956T patent/PT1067934E/pt unknown
- 1999-03-29 WO PCT/EP1999/002277 patent/WO1999051237A1/en not_active Ceased
- 1999-04-01 US US09/283,945 patent/US6040301A/en not_active Expired - Fee Related
- 1999-07-22 US US09/358,772 patent/US6114324A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BR9909357A (pt)	2000-12-12
HK1032012A1 (en)	2001-07-06
CA2326356C (en)	2008-06-03
DE69913116T2 (de)	2004-06-03
EP1067934A1 (de)	2001-01-17
US6040301A (en)	2000-03-21
AU747975B2 (en)	2002-05-30
CA2326356A1 (en)	1999-10-14
EP1067934B1 (de)	2003-11-26
ES2212550T3 (es)	2004-07-16
DE69913116D1 (de)	2004-01-08
PT1067934E (pt)	2004-03-31
WO1999051237A1 (en)	1999-10-14
ATE254918T1 (de)	2003-12-15
AU3604899A (en)	1999-10-25
US6114324A (en)	2000-09-05

Publication	Publication Date	Title
PT1067934E (pt)	2004-03-31	Solucao anti-depressiva liquida oral
IS2863B (is)	2013-12-15	Arípíprazóllausn til gjafar um munn
WO2000002542A3 (de)	2000-06-22	Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum
TR200200579T2 (tr)	2002-12-23	Amino-tirazolpiridin türevleri.
BR0015624A (pt)	2002-07-30	Uso de um composto, composto, composição farmacêutica, e, método de tratamento ou profilaxia de doenças ou condições humanas
BR0209579A (pt)	2004-06-22	Derivados de 2-piridina ciclohexana-1, 4 diamina substituìdos
DE50210313D1 (de)	2007-07-26	Amphotere sterole und deren verwendung
BR9906758A (pt)	2002-01-15	Método e composição para transferir zinco para a membrana nasal
BR9804437A (pt)	2001-05-02	Compostos para a osteoporose
ES2184293T3 (es)	2003-04-01	Composiciones farmaceuticas administrables por via oral que comprenden una benzhidrilpiperazina y una ciclodextrina.
ATE357438T1 (de)	2007-04-15	1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
BR9804027A (pt)	2001-04-24	Novos beta-ceto ésteres
ATE249205T1 (de)	2003-09-15	Wässrige suspension zur nasalen verabreichung von loteprednol
BR0105563A (pt)	2002-04-02	Derivados e análogos de galantamina
NO20014241D0 (no)	2001-08-31	C16-umettede FP-selektive prostaglandinanaloger
DK0988302T3 (da)	2003-06-02	Benzonaphthyridiner
PT1204658E (pt)	2003-08-29	Agonistas benzofurilpiperazina de serotonina
NO973589L (no)	1997-10-08	Medikament for behandling av tvangstanke-tvangshandlingsproblemer, sövnapne, seksuelle funksjonsforstyrrelser, emesi og reisesyke
BR0114395A (pt)	2005-08-16	Composição farmacêutica para administração por suprimento via oral
ATE266029T1 (de)	2004-05-15	Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
BR9812982A (pt)	2000-08-08	Agente anti-reumático
MXPA03008837A (es)	2004-05-05	Una composicion farmaceutica estable de pravastatina.
BR9712033A (pt)	2000-01-18	Composição farmacêutica para tratamento de doenças virais.
PE20030236A1 (es)	2003-04-10	Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
BR0114459A (pt)	2003-09-23	Derivados substituìdos de 5-amino-1-penten-3-ol substituidos